Identification of a Novel ERK5 (MAPK7) Inhibitor, MHJ-627, and Verification of Its Potent Anticancer Efficacy in Cervical Cancer HeLa Cells.

Hwang, Jeonghye; Moon, Hyejin; Kim, Hakwon; Kim, Ki-Young

Hwang, Jeonghye; Moon, Hyejin; Kim, Hakwon; Kim, Ki-Young.

Afiliação

Hwang J; Department of Genetics and Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea.
Moon H; Department of Applied Chemistry, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Yongin 17104, Republic of Korea.
Kim H; Department of Applied Chemistry, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Yongin 17104, Republic of Korea.
Kim KY; Department of Genetics and Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea.

Curr Issues Mol Biol ; 45(7): 6154-6169, 2023 Jul 24.

Article em En | MEDLINE | ID: mdl-37504304

Palavras-chave

BMK1; ERK5; ERK5 inhibitor; MAPK7; anticancer; imidazolium; oncotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Curr Issues Mol Biol Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google